Supplements Science

Nicotinamide Riboside Supplement: Evidence Review

Written by ReCellence™ Editorial Team, Health Content SpecialistsReviewed by Medical Review Board, MD, PhDLast reviewed: March 8, 2026

Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.

What This Page Explains

Nicotinamide riboside (NR) is a form of vitamin B3 and NAD+ precursor that enters the salvage pathway via NR kinases. It has more published human clinical trial data than NMN and has been granted Generally Recognized as Safe (GRAS) status.

From the Lab to Your Cells: 5 Compounds That Actually Reach the Mitochondria

Piperine-enhanced bioavailability ensures these research-backed compounds get where they need to go — your cellular powerhouses.

Detailed Evidence

NR is phosphorylated by NR kinase enzymes (NRK1, NRK2) to produce NMN, which is then converted to NAD+ by NMNAT. This two-step conversion has been well-characterized in human studies. Martens et al. (2018) demonstrated that chronic NR supplementation (1,000 mg/day for 6 weeks) safely elevated NAD+ by approximately 60% in healthy middle-aged and older adults, with trends toward improved blood pressure. Unlike niacin, NR does not cause flushing. It has a favorable safety profile across multiple clinical trials at doses up to 2,000 mg/day. Current limitations include the absence of large-scale, long-duration clinical trials demonstrating hard clinical endpoints (mortality, disease incidence) in humans.

Evidence Hierarchy

Strongest

Systematic Reviews & Meta-Analyses

Multiple high-quality trials combined

Strong

Randomized Controlled Trials (RCTs)

Gold standard for treatment efficacy

Moderate

Observational Studies

Can show associations, not causation

Limited

Case Reports & Expert Opinion

Hypothesis-generating only

Weakest

Preclinical (Lab/Animal) Studies

Should NOT be extrapolated to humans

Don't Let Another Year of Cellular Decline Pass You By

Every year you wait, your NAD+ drops further, your mitochondria accumulate more damage, and recovery gets harder. Start today.

Study Quality Indicators

Higher Quality Indicators

  • Large sample size (hundreds to thousands)
  • Randomized and blinded design
  • Placebo-controlled comparison
  • Published in peer-reviewed journals
  • Replicated in multiple studies
  • Registered trial protocol before starting

Lower Quality Indicators

  • Small sample size (under 100)
  • No control group or blinding
  • Manufacturer-funded with conflicts
  • Only animal/cell studies
  • Never replicated
  • Published in predatory journals

Important Limitations

  • • Supplement research often has methodological limitations
  • • Results from one study may not generalize to all people
  • • Marketing claims often exceed what research supports
  • • Absence of evidence is not evidence of absence
  • • Individual response to supplements varies widely

Quick Answers

Q1.

What is nicotinamide riboside (NR)?

A form of vitamin B3 and NAD+ precursor that enters cells via NR kinases; sold as Niagen.

Q2.

How much NR should I take?

Typical doses are 300–1,000 mg/day; studied up to 2,000 mg/day.

Q3.

Does NR raise NAD+ levels?

Yes — 1,000 mg/day elevated NAD+ ~60% in older adults over 6 weeks.

Q4.

NR vs NMN: what's the difference?

NR has more human data and GRAS status; NMN is one enzymatic step closer to NAD+.

Q5.

Is NR safe?

Yes — GRAS status; no serious adverse events in published trials up to 2,000 mg/day.

Q6.

Does NR help with cardiovascular health?

Reduced systolic BP by 4 mmHg and arterial stiffness in one 6-week trial.

Q7.

Can NR improve exercise performance?

Evidence is mixed; raises muscle NAD+ but performance benefits are inconsistent.

Q8.

What is Niagen?

The branded, patented form of NR with GRAS notification (GRN 635).

Q9.

Does NR help with brain health?

Under investigation (NICE-PD trial) for Parkinson's; preliminary brain NAD+ elevation.

Q10.

When should I take NR?

Morning is common; can be taken with or without food.

Q11.

How long does NR take to work?

Blood NAD+ rises within hours; sustained elevation seen over weeks.

Q12.

Does NR help with weight loss?

No consistent evidence for weight loss as a primary outcome.

Q13.

Can I get NR from food?

Trace amounts in milk; dietary intake is negligible vs supplemental doses.

Q14.

Is NR better than niacin?

NR avoids niacin flush and raises NAD+ efficiently; niacin also works but causes flushing.

Q15.

Does NR interact with medications?

No major interactions established; monitor with NAD+-dependent therapies.

Key Research Facts

1

NR supplementation at 1,000 mg/day elevated NAD+ by approximately 60% in healthy middle-aged and older adults

Strong Evidence

Martens CR, et al. Nat Commun. 2018;9(1):1286.

2

NR reduced systolic blood pressure by 4 mmHg and arterial stiffness (pulse wave velocity) in older adults after 6 weeks

Moderate Evidence

Martens CR, et al. Nat Commun. 2018;9(1):1286.

3

NR has GRAS (Generally Recognized as Safe) status from the FDA and has been studied at doses up to 2,000 mg/day

Strong Evidence

FDA GRAS Notice No. GRN 635.

4

NR enters cells via equilibrative nucleoside transporters (ENTs) and is converted to NAD+ via NR kinases

Strong Evidence

Ratajczak J, et al. Nat Commun. 2016;7:13103.

5

A single dose of NR (250-1000mg) increased blood NAD+ metabolome within 24 hours in healthy volunteers

Strong Evidence

Trammell SA, et al. Nat Commun. 2016;7:12948.

6

NR supplementation reduced markers of inflammation (IL-6, TNF-α) in some clinical trials

Moderate Evidence

Elhassan YS, et al. Cell Rep. 2019;28(7):1717-1728.

7

NR penetrates skeletal muscle and increases muscle NAD+ levels in humans, as shown by muscle biopsy analysis

Strong Evidence

Elhassan YS, et al. Cell Rep. 2019;28(7):1717-1728.

8

The NICE-PD trial is investigating NR for Parkinson's disease, with preliminary results showing brain NAD+ elevation

Moderate Evidence

ClinicalTrials.gov — NCT03816020.

9

NR is more shelf-stable than NMN and does not require refrigeration under normal storage conditions

Strong Evidence

Product stability studies.

10

No serious adverse events have been attributed to NR supplementation in published human clinical trials

Strong Evidence

Conze D, et al. Food Chem Toxicol. 2019;126:78-90.

Continue Your Research

Explore related topics and take the next step in your cellular health journey.

Citations & External Resources

Review

Nature Communications: NR Cardiovascular Trial (Martens)

Review

Cell Reports: NR Increases Muscle NAD+ (Elhassan)

Review

Examine.com NR Research Summary

Regulatory

FDA GRAS Notice for Niagen (NR)

Institution

ClinicalTrials.gov NR Studies

Review

Nature Communications: NR Pharmacokinetics (Trammell)

The Cellular Renewal Protocol Trusted by 12,000+ Customers

Real people who decided to target the root cause of aging — not just the symptoms. Join them.

Related Reading

References (4)

Written by

ReCellence™ Editorial Team

Health Content Specialists

Medically reviewed by

Medical Review Board

MD, PhD

Last updated: March 8, 2026

Last medical review: March 8, 2026